Platelet BioGenesis
Producing the world’s first donor-independent human platelets.
Launch date
Employees
Market cap
-
Enterprise valuation
$302—453m (Dealroom.co estimates Nov 2021.)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Grant | ||
N/A | Seed | ||
N/A | $1.1m | Debt | |
$600k | Grant | ||
$10.0m | Series A | ||
$3.5m | Grant | ||
N/A | N/A | Series A | |
$26.0m | Series A | ||
$2.3m | Grant | ||
$75.5m | Series B | ||
Total Funding | $118m |
Recent News about Platelet BioGenesis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.